As previously reported, BofA analyst Julien Dumoulin-Smith downgraded Stem to Underperform from Neutral with a price target of $5, down from $9, telling investors that the firm’s "confidence in estimates is increasingly strained." While management is suggesting that a rapid scale up in services can bridge a deceleration in hardware sales, the firm lacks confidence in the medium-term with the potential for a slower realization on a build-up of recurring software revenues, it said. BofA has reduced its estimates "modestly" and calls consensus "a bit generous."
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on STEM:
- Buy These Clean Energy Stocks, Morgan Stanley Says, Forecasting Over 100% Upside
- Stem assumed with an Overweight at Morgan Stanley
- 3 Best Stocks to Buy Now, 3/30/2023, According to Top Analysts
- Stem price target lowered to $11 from $14 at Guggenheim
- Stem price target lowered to $12 from $17 at Susquehanna